Lying Positions in Intramuscular Injection

NCT07586605 | Not Yet Recruiting

• 1 other identifier: 2026/208
• Study Type: interventional
• Target: 111
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to examine the effects of intramuscular (IM) injections administered in three different lying positions (supine, prone, and lateral) into the ventrogluteal site on patient pain, comfort, and procedural satisfaction. The study will be conducted as a randomized controlled experimental trial with three groups. In Experimental Group 1, patients will be placed in the supine position; in Experimental Group 2, the lateral position; and in Experimental Group 3, the prone position prior to the injection procedure, followed by an IM injection into the ventrogluteal site. Subsequent to the procedure, patients' pain, comfort, and procedural satisfaction levels will be assessed.

Conditions

Ventrogluteal Injections

Keywords

intramuscular injection; lying position; pain; patient satisfaction

Outcome Measures

Primary Outcomes (1)

• Visual Analog Scale (VAS) Score for Pain

  patient's pain level (0-10)

  during the procedure

Secondary Outcomes (2)

• Procedural Satisfaction Score

  during the procedure

• Patient Comfort Level

  During the procedure

Study Arms (3)

experimental group 1

EXPERIMENTAL

Supine position before intramuscular injection

Procedure: Lying before procedure

experimental group 2

EXPERIMENTAL

Lateral position before intramuscular injection

Procedure: Lying before procedure

experimental group 3

EXPERIMENTAL

Prone position before intramuscular injection

Procedure: Lying before procedure

Interventions

Lying before procedure PROCEDURE

Lying position before intramuscular injection

experimental group 1; experimental group 2; experimental group 3

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Being 18 years of age or older,
• Having received an IM injection at least one week prior to the study,
• Absence of scars, ecchymosis, or hematomas at the injection site,
• Having a BMI between 18.5 and 24.9 kg/m²,
• Absence of lower extremity paralysis,
• Not receiving any oral or parenteral analgesic treatment prior to the injection.

You may not qualify if:

• Failure of the patient to respond to the questions in the post-procedure data collection form.

Sponsors & Collaborators

• University of Yalova: lead

Study Sites (1)

Yalova University

Yalova, 77300, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pressure Ulcer; Pain; Patient Satisfaction

Condition Hierarchy (Ancestors)

Skin Ulcer; Skin Diseases; Skin and Connective Tissue Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Treatment Adherence and Compliance; Health Behavior; Behavior

Central Study Contacts

Handan Eren, PhD

CONTACT

+905438712771; erennhandan@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Model Details: Randomized controlled study

Study Record Dates

• First Submitted: April 30, 2026
• First Posted: May 14, 2026
• Study Start: April 30, 2026
• Primary Completion (Estimated): June 30, 2026
• Study Completion (Estimated): August 30, 2026
• Last Updated: May 22, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)